These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19843623)

  • 1. Effect of preoperative atorvastatin therapy on paraoxonase activity and oxidative stress after coronary artery bypass grafting.
    Kurban S; Mehmetoglu I; Ege E
    Perfusion; 2009 Jul; 24(4):271-6. PubMed ID: 19843623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase and arylesterase activities in coronary artery disease.
    Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I
    Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis.
    Koc S; Aksoy N; Bilinc H; Duygu F; Uysal IÖ; Ekinci A
    Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1364-7. PubMed ID: 21893350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative status and serum PON1 activity in beta-thalassemia minor.
    Selek S; Aslan M; Horoz M; Gur M; Erel O
    Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity.
    Antoniades C; Bakogiannis C; Tousoulis D; Reilly S; Zhang MH; Paschalis A; Antonopoulos AS; Demosthenous M; Miliou A; Psarros C; Marinou K; Sfyras N; Economopoulos G; Casadei B; Channon KM; Stefanadis C
    Circulation; 2010 Sep; 122(11 Suppl):S66-73. PubMed ID: 20837928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery.
    Song YB; On YK; Kim JH; Shin DH; Kim JS; Sung J; Lee SH; Kim WS; Lee YT
    Am Heart J; 2008 Aug; 156(2):373.e9-16. PubMed ID: 18657672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R; Mahajan M; Singh B; Bal BS; Kant R
    J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients.
    Yildiz A; Gur M; Demirbag R; Yilmaz R; Akyol S; Aslan M; Erel O
    Clin Biochem; 2008 Jul; 41(10-11):779-84. PubMed ID: 18355454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early effects of sodium valproate monotherapy on serum paraoxonase/arylesterase activities.
    Karikas GA; Schulpis KH; Bartzeliotou A; Regoutas S; Thanopoulou C; Papaevangelou V; Giannoulia-Karantana A; Papassotiriou I; Fytou-Pallikari A
    Scand J Clin Lab Invest; 2009; 69(1):31-5. PubMed ID: 19016076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery.
    Chello M; Patti G; Candura D; Mastrobuoni S; Di Sciascio G; Agrò F; Carassiti M; Covino E
    Crit Care Med; 2006 Mar; 34(3):660-7. PubMed ID: 16505650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials).
    Brilakis ES; de Lemos JA; Cannon CP; Wiviott SD; Murphy SA; Morrow DA; Sabatine MS; Banerjee S; Blazing MA; Califf RM; Braunwald E
    Am J Cardiol; 2008 Sep; 102(5):552-8. PubMed ID: 18721511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of atorvastatin on heart rate variability and lipoproteins in patients treated with coronary bypass surgery.
    Riahi S; Schmidt EB; Amanavicius N; Karmisholt J; Jensen HS; Christoffersen RP; Niebuhr U; Christensen JH; Toft E
    Int J Cardiol; 2006 Aug; 111(3):436-41. PubMed ID: 16290290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis.
    Kirbas A; Kirbas S; Anlar O; Efe H; Yilmaz A
    J Clin Neurosci; 2013 Aug; 20(8):1106-9. PubMed ID: 23669169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy.
    Rosenblat M; Hayek T; Hussein K; Aviram M
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):175-80. PubMed ID: 14592851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative statin therapy and troponin T predict early complications of coronary artery surgery.
    Pascual DA; Arribas JM; Tornel PL; Marín F; Oliver C; Ahumada M; Gomez-Plana J; Martínez P; Arcas R; Valdes M
    Ann Thorac Surg; 2006 Jan; 81(1):78-83. PubMed ID: 16368340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin.
    Samy W; Hassanian MA
    Arab J Gastroenterol; 2011 Jun; 12(2):80-5. PubMed ID: 21684478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol.
    Bergheanu SC; Van Tol A; Dallinga-Thie GM; Liem A; Dunselman PH; Van der Bom JG; Jukema JW
    Curr Med Res Opin; 2007 Sep; 23(9):2235-40. PubMed ID: 17692153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
    Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
    Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV; Papathanasiou AI; Rodis FI; Elisaf M; Goudevenos JA; Tselepis AD
    Circulation; 2004 Mar; 109(11):1335-8. PubMed ID: 15023882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.